The
following potentially dilutive securities have been excluded from the computations of diluted weighted average shares outstanding because
they would be anti-dilutive:
Schedule of Computations of Diluted Weighted Average Shares Outstanding
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Option and RSUs to purchase common stock | |
| 158,966 | | |
| 18,258 | | |
| 158,966 | | |
| 18,258 | |
| Warrants to purchase common stock | |
| 381,953 | | |
| 383,159 | | |
| 381,953 | | |
| 383,159 | |
| Convertible notes to purchase common stock | |
| 559,519 | | |
| 525,236 | | |
| 559,519 | | |
| 525,236 | |
| Total potential shares | |
| 1,100,438 | | |
| 926,653 | | |
| 1,100,438 | | |
| 926,653 | |
|